Author:
Haupt-Schott Ingrid,Hamilton Geraldine,Perros Petros
Publisher
Springer International Publishing
Reference52 articles.
1. Baloch et al 2000 and Rivera et al 2009 as cited in Ohori, P. FNA cytopathology and molecular test characteristics in the changing landscape of papillary thyroid carcinoma. J Basic Clin Med. 2015;4(2):103–9.
2. Banach R, Bartès B, Farnell K, Rimmele H, Shey J, Singer S, Verburg FA, Luster M. Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens). 2013;12:428–38.
3. Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20:135–46.
4. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013;347:f4706.
5. Bychkov A. Thyroid gland. Miscellaneous AJCC/TNM staging. 2018.
PathologyOutlines.com
.
http://www.pathologyoutlines.com/topic/thyroidstaging.html
. Accessed 16 Apr 2018.